Document is current
Any future updates will be listed below
-
Authors
Atallah, Mark
Nasrallah, Nadim
Harb, Tarek
Valenta, Ines
Schindler, Thomas H.
Wallace, Amelia S.
Tsimikas, Sotirios
Gerstenblith, Gary
Leucker, Thorsten M. https://orcid.org/0000-0003-2569-6617
- License Information
-
More Information
Article History
Received: 5 January 2026
Accepted: 22 April 2026
First Online: 29 May 2026
Competing interests
: No specific funding was received for this analysis. Although prior related work by the authors has been supported by Amgen, the present study was conducted independently and without financial support from any commercial entity. T.M.L. has received research grant support from the National Heart, Lung, and Blood Institute (NHLBI), Merck, Novartis and Amgen, outside of and not relevant to the submitted work. S.T. is a co-inventor and receives royalties from patents owned by the University of California San Diego (UCSD), is a co-founder and has an equity interest in Oxitope and Kleanthi Diagnostics, and has a dual appointment at UCSD and Ionis Pharmaceuticals. The terms of this arrangement have been reviewed and approved by the UCSD in accordance with its conflict-of-interest policies. S.T. is supported by NHLBI grant nos. R01 HL159156 and HL170224. The other authors declare no competing interests.
